Insider Transactions in Q4 2021 at P3 Health Partners Inc. (PIII)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 03
2021
|
Sherif Abdou Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
28,185,982
+50.0%
|
$13,219,225,558
$469.77 P/Share
|
|
Dec 03
2021
|
Amir Bacchus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
3,758,130
+50.0%
|
$1,409,298,750
$375.81 P/Share
|
|
Dec 03
2021
|
Amir Bacchus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,032,528
+50.0%
|
$22,593,889,584
$1503.25 P/Share
|
|
Dec 03
2021
|
Eric Atkins Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
450,517
+50.0%
|
$20,273,265
$45.05 P/Share
|
|
Dec 03
2021
|
Gregory N. Kazarian Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,177,659
+50.0%
|
$137,786,103
$117.77 P/Share
|
|
Dec 03
2021
|
Thomas Edmunds Price Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,177,659
+50.0%
|
$137,786,103
$117.77 P/Share
|
|
Oct 04
2021
|
Robert G Zimmerman Director |
BUY
Conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Oct 04
2021
|
John R Svoboda Director |
BUY
Conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Oct 04
2021
|
Foresight Sponsor Group, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
6,843,525
+47.63%
|
-
|
|
Oct 04
2021
|
Brian R Gamache Director |
BUY
Conversion of derivative security
|
Direct |
25,000
+50.0%
|
-
|
|
Oct 04
2021
|
Michael Balkin > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,843,525
+47.63%
|
-
|
|
Oct 04
2021
|
Gregory D Wasson Director |
BUY
Conversion of derivative security
|
Indirect |
6,843,525
+47.63%
|
-
|